GT Biopharma (GTBP) Interest & Investment Income (2021 - 2026)
GT Biopharma's Interest & Investment Income was $67,000 in Q1 2026, up 109.4% from $32,000 a year earlier and up 294.1% from the prior quarter.
Powered by 
Analysis
GT Biopharma (GTBP) Interest & Investment Income (2021 - 2026) Analysis & Trends
On a trailing twelve-month basis, GT Biopharma's Interest & Investment Income was $158,000 through Mar 31, 2026, down 45.9% year-over-year; for FY2025, it was $123,000, down 69.4% from FY2024.
- Interest & Investment Income shows a four-year compound annual growth rate of 34.1% (FY2021 to FY2025).
- In earlier years, Interest & Investment Income was $402,000 in FY2024 (-48.5%), $780,000 in FY2023 (+167.1%), $292,000 in FY2022 (+668.4%) and $38,000 in FY2021.
- The Q1 2026 figure marks the highest quarterly Interest & Investment Income since Q3 2024.
- Compared with a year earlier, Interest & Investment Income was higher in 1 of the last seven quarters, with an average decline of 42.0%.
- The best year-over-year quarter for Interest & Investment Income over five years was Q1 2026 (growth of 109.4%); the worst was Q1 2025 (a decline of 77.5%).
- Per Business Quant data, GTBP's Interest & Investment Income in the three quarters before Q1 2026 was $17,000 (Q4 2025), $36,000 (Q3 2025) and $38,000 (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 186.00 Mn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | - |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 80.00 Mn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | - |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | - |
| 10 | GT Biopharma | 7.68 Mn | -15.81 Mn | - | 67,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 67,000.00 |
| Dec 31, 2025 | 17,000.00 |
| Sep 30, 2025 | 36,000.00 |
| Jun 30, 2025 | 38,000.00 |
| Mar 31, 2025 | 32,000.00 |
| Dec 31, 2024 | 59,000.00 |
| Sep 30, 2024 | 96,000.00 |
| Jun 30, 2024 | 105,000.00 |
| Mar 31, 2024 | 142,000.00 |
| Dec 31, 2023 | 220,000.00 |
| Sep 30, 2023 | 216,000.00 |
| Mar 31, 2023 | 164,000.00 |
| Dec 31, 2021 | 6,000.00 |
| Sep 30, 2021 | 32,000.00 |
API Access
GT Biopharma Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=GTBP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "GTBP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=GTBP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();